Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is N/A as of Tuesday, October 6, 2026.
DEBT TO ASSETS RATIO
N/A
MiniMed Group, Inc.
Market Cap
$560.00M
Debt to Assets Ratio
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $560.75M | 0.00% |
| CorMedix Inc. (CRMD)vs › | $563.68M | 0.16% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $556.18M | 0.19% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $551.43M | 0.00% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $569.29M | 0.01% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $570.25M | 0.45% |
| Immix Biopharma, Inc. (IMMX)vs › | $541.86M | 0.00% |
| Delcath Systems, Inc. (DCTH)vs › | $538.54M | 0.02% |
| Crescent Biopharma, Inc. (CBIO)vs › | $536.92M | 0.01% |
Debt/Assets
N/A
Debt/Equity
N/A
Current Ratio
N/A
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
